Precision Optics Corporation, Inc. (POCI)
NASDAQ: POCI · Real-Time Price · USD
4.990
+0.770 (18.25%)
Nov 11, 2025, 12:05 PM EST - Market open
POCI Market Cap
POCI has a market cap or net worth of $38.5 million as of November 11, 2025. Its market cap has increased by 52.16% in one year.
Market Cap
38.50M
Enterprise Value
34.05M
1-Year Change
52.16%
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since December 1, 1998, POCI's market cap has increased from $6.70M to $38.50M, an increase of 474.57%. That is a compound annual growth rate of 6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 32.60M | 6.54% |
| Dec 31, 2024 | 30.60M | -16.16% |
| Dec 29, 2023 | 36.50M | 16.24% |
| Dec 30, 2022 | 31.40M | -21.70% |
| Dec 31, 2021 | 40.10M | 102.53% |
| Dec 31, 2020 | 19.80M | -14.66% |
| Dec 31, 2019 | 23.20M | 44.10% |
| Dec 31, 2018 | 16.10M | 292.68% |
| Dec 29, 2017 | 4.10M | -6.82% |
| Dec 30, 2016 | 4.40M | -12.00% |
| Dec 31, 2015 | 5.00M | 31.58% |
| Dec 31, 2014 | 3.80M | -5.00% |
| Dec 31, 2013 | 4.00M | 17.65% |
| Dec 31, 2012 | 3.40M | 100.00% |
| Dec 30, 2011 | 1.70M | 750.00% |
| Dec 31, 2010 | 200.00K | -81.82% |
| Dec 31, 2009 | 1.10M | 450.00% |
| Dec 31, 2008 | 200.00K | -94.44% |
| Dec 31, 2007 | 3.60M | -35.71% |
| Dec 29, 2006 | 5.60M | 124.00% |
| Dec 30, 2005 | 2.50M | -71.26% |
| Dec 31, 2004 | 8.70M | 135.14% |
| Dec 31, 2003 | 3.70M | 42.31% |
| Dec 31, 2002 | 2.60M | -65.79% |
| Dec 31, 2001 | 7.60M | -69.48% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |